[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $crvs

Corvus Pharmaceuticals presents positive Phase X T-Cell Lymphoma results for Soquelitinib, sparking significant social media buzz and analyst attention. The company's advancements are driving high engagement, with a notable increase in mentions and posts.

### About $crvs
Corvus Pharmaceuticals is a biotechnology company focused on developing therapies for cancer and inflammatory diseases.  

### Insights
- $crvs engagements hit 94.6K which is XXX% higher than it's daily average.
- $crvs engagements is up XXXXXX% from the previous week.
- $crvs mentions is up XXXX% from the previous week.
- $crvs posts created is up XX% from the previous week.

### Engagements: XXXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/interactions.tsv)  
Current Value: XXXXXX  
Daily Average: XXXXXX  
X Week: XXXXXX +219%  
X Month: XXXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXX +75%  
1-Year High: XXXXXXX on 2025-01-02  
1-Year Low: XXXXX on 2025-03-16  

Engagements by network (24h):
X: XXXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XXX  
X Week: XXX +14%  
X Month: XXX -XX%  
X Months: XXXXX -XX%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2024-12-13  
1-Year Low: XX on 2025-12-07  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $crvs in the last XX hours which is down XXXX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX +9.50%  
X Month: XXX -XX%  
X Months: XXXXX +96%  
X Year: XXXXX +232%  
1-Year High: XXX on 2025-06-29  
1-Year Low: XX on 2025-02-10  

The most influential creators that mention $crvs in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)             | X    | XXXXXX    | X     | XXXXX       |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | X    | XXXXX     | XX    | XXXXX       |
| [@Pharmdca](/creator/twitter/Pharmdca)               | X    | XXXXXXX   | X     | XXX         |
| [@OzmosiHealth](/creator/twitter/OzmosiHealth)       | X    | XXXXX     | X     | XXX         |
| [@mtheory11bio](/creator/twitter/mtheory11bio)       | X    | XXXXX     | X     | XXX         |
| [@Fredbenz0](/creator/twitter/Fredbenz0)             | X    | XXXXX     | X     | XXX         |
| [@MarketRebels](/creator/twitter/MarketRebels)       | X    | XXXXXXX   | X     | XXX         |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | X    | XXX       | X     | XXX         |
| [@financebully](/creator/twitter/financebully)       | X    | XXX       | X     | XXX         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | XX   | XXXXX     | X     | XXX         |

[View More](/list/creators/$crvs/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crvs/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crvs/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-02-09  
1-Year Low: XX% on 2025-03-17  

Most Supportive Themes:
- Pipeline Milestones and Data Readouts: (40%) Corvus Pharmaceuticals is advancing its lead asset, Soquelitinib, with Phase X extension cohorts completed and Phase 2/3 trials on track, generating anticipation for upcoming data releases.
- Analyst Coverage and Price Targets: (30%) Barclays initiated coverage with an Overweight rating and a $XX price target, signaling positive sentiment and potential upside from institutional analysis.
  
Most Critical Themes:
- Net Loss and Financial Performance: (10%) Corvus Pharmaceuticals reported a net loss of $10.2M in Q3, a significant increase from the previous year, raising concerns about financial sustainability.
  

### Top $crvs Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$CRVS Corvus presented P1 T-Cell Lymphoma results on 2025-12-08 for Soquelitinib More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998503188446507194) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T21:21Z 3011 followers, XXX engagements


"$CVS $MRNA $CNM $ACHR $OCUL $DECK $MBLY $TECH $EXE $CRVS $PBF $SNAP $HBM $OPEN $TWLO $PAAS $S $PSKY $AM $TEX $ON $AEO $KNX $ZM $TOL 🎯TopUnusual Report-Part X 🎯Verified Dec XX Data ⚠These 72of8000+ Verified & Represent Top Bullish Unusual Options Stocks"  
[X Link](https://x.com/Fredbenz0/status/1998498638444793923) [@Fredbenz0](/creator/x/Fredbenz0) 2025-12-09T21:03Z 2692 followers, XX engagements


"$opal $arqt $crvs $ivvd Small caps with momo"  
[X Link](https://x.com/STvrosb/status/1998420275596284312) [@STvrosb](/creator/x/STvrosb) 2025-12-09T15:51Z XXX followers, XXX engagements


"$CRH $CRVS $FROG $IMMP $PLBY $GPCR $CELH $CMG $DBRG $DUOL $PGR $PRMB $WRBY $OLLI $PHR $S $ASO $KURA $TMC $WVE $ZIM $CRML $LUNR $CFLT $CNM $KODK $PSTG $AFYA $ASAN $DAR $GTLB $IONS $JANX 💎 12/08/25-Part X 💎Top Unusual Implied Volatility Watchlist & Database 💎IV Change Details For 100+ Stocks (Secondary Unusual Options Alert)"  
[X Link](https://x.com/Fredbenz0/status/1998402730482610336) [@Fredbenz0](/creator/x/Fredbenz0) 2025-12-09T14:41Z 2692 followers, XXX engagements